Good morning, everybody. Thank you for taking the time to join us today. As you may have seen from our press release this morning, we delivered strong financial results in 2022. We made further operational and strategic progress, and we also performed well on our corporate responsibility priorities. Underlying revenue growth was 9%. Underlying adjusted operating profit growth was 15%. Adjusted earnings per share growth was 10% at constant currencies, and we're proposing an increase in the pound sterling full year dividend of 10%. All 4 business areas grew well, with underlying adjusted operating profit growth in line with or ahead of underlying revenue growth. So let's look at the results for each business area. In Risk, strong fundamentals continue to drive underlying revenue growth. Underlying revenue growth was 8%, up from 7% in the first 9 months of the year, with underlying adjusted operating profit growth broadly in line with underlying revenue growth. Business Services, which represents around 45% of divisional revenue, continued to deliver strong revenue growth in financial crime and compliance and fraud and identity. And we have recently strengthened our customer proposition with small acquisitions in compliance and behavioral biometrics. In Insurance, representing just under 40% of divisional revenue, the positive momentum that started in the first half strengthened through the remainder of the year supported by further improvement in key market factors such as shopping activity. Specialized industry data services, which represents just over 10% of divisional revenue, saw strong growth overall, with commodity intelligence growing particularly strongly and other segments, including aviation, returning to historical growth rates. Government, representing just over 5% of divisional revenue, continued to grow strongly. Going forward, we expect strong underlying revenue growth in line with historical trends, with underlying adjusted operating profit growth broadly matching underlying revenue growth. In…

Thank you, Erik. Good morning, everyone. Let me start by providing more detail on the group financials. As Erik said, underlying revenue growth was 9%, the underlying adjusted operating profit growth well ahead of that of 15%. As a result, the adjusted operating margin improved by almost 1 percentage point to 31.4%. The improved operating result flowed through to adjusted earnings per share, which increased 10% at constant currency despite a higher interest and tax rates. Returns continued to improve despite the higher tax rate, with ROIC up another 60 basis points, now at 12.5%. Cash conversion was strong at 101%, contributing to a further reduction in leverage to 2.1x down from 2.4x at the end of 2021. Given the strong overall performance, we have been able to increase the proposed full year dividend by 10% to 54.6 per share. Looking at revenue, you can see the continued strong growth in Risk and the improved growth rates in STM and Legal. Those improved growth rates, together with the continued recovery in Exhibitions, took underlying revenue growth for the group as a whole up to 9%. Including Exhibitions by annual events, total growth at constant currency was 11%. And of course, with 60% of our revenue is generated in North America, there was a significant benefit from the stronger dollar, with sterling revenue up 18% overall. Risk delivered strong underlying growth in adjusted operating profit, in line with revenue growth. STM and Legal both delivered underlying profit growth ahead of revenue growth. Portfolio effects were a slight drag on profit growth in each of these business areas, but all of them benefited significantly from currency movements. Exhibitions' profit recovered, reaching about half of 2019's level as activity increased, and we benefited from the lower cost structure. Combined with the strong performance…

Thank you, Nick. Just to summarize what we've covered this morning. In 2022, we delivered strong financial results. We made further operational and strategic progress, and we also performed well on our corporate responsibility priorities. The improving long-term growth trajectory is being driven by the ongoing shift in our business mix towards higher-growth analytics and decision tools, and we remain focused on managing our cost growth below revenue growth. Going forward, momentum remains strong across the group, and we expect underlying growth rates in revenue and adjusted operating profit to remain above historical trends, driving another year of strong growth in adjusted earnings per share on a constant currency basis. And with that, I think we're ready to go to questions.

[Operator Instructions] We will take our first question from Adam Berlin from UBS.

It's Adam Berlin from UBS. I just have some questions on the STM division. In the past, you've given us some information about the number of submissions, the number of open-access articles, et cetera, rather than just kind of the commentary you provided. Any physical numbers you can give us about the number of submissions, the number of open-access articles you published or the open access growth rate, that would be really helpful. And then my second question was, you mentioned that the number of submissions have actually increased above that very high level we had last year in 2020. Can you talk a little about what's driving that? And are you rubbing up against any kind of limit to how many articles you can process because of things like capacity and peer review or any restrictions that are going to stop you continuing to grow the number of articles that you receive and you publish?

Okay. Let me cover those. Total submission growth this year to our journals is back up now to sort of the mid- to high single digits, which has been our very long-term average, and that's now on top of what was a little bit of a jump and then leveling off a little during COVID, which has some unique characteristics. So this is back to the long-term growth right now of strong submission growth. And you also asked specifically about submissions, direct open access sort of pay-to-publish or to our author-pays journals. That's growing pretty close to 30% this year. And then you ask, is there a limit to the processing or the scale here? I think I have to answer this in a way that gives you a little bit of history. The long-term growth rate in submissions to us has probably been, on average, growing in the high single digits for a very long time, I mean, almost per decade. And what's behind this is the increase in total number of scientists, researchers in the world that typically has grown sort of 3% to 4% for over a decade and continues to drive the activity. Then the increasing information intensity of science means, of course, that people document more, they research more, they have more powerful tools. So that's why they can drive a submission growth rate that's above the number of -- the growth in number of researchers. We continue to scale up our operations. We continue to scale up our network with that growing number of researchers in the world. And we also leverage lots of different technologies and process innovations, in particular, leveraging AI, technology and machine learning tools to make sure that, that machinery works at a much larger scale. And I don't see any end point or limit to this where we would hit any endpoint on this growth in the world of science.

And maybe just how many articles in total did you publish? Can you tell us that?

Yes, it was about 600,000, just over 600,000, of which about 1/4 are open access.

Okay. So similar to last year?

Yes.

Yes. Yes, a little bit up because the -- there is a delay in submissions to acceptances to publish and as the number of submissions leveled off a little bit the year before and now has gone back to the mid- to high-single-digits growth rate of submissions, that means that the number of articles published has a little bit of a time lag as it's come through and get registered. So that's why you can see the sort of the keeping up at the level it led to a small increase this year, a number of articles published, but what's in the pipeline in terms of articles submitted and accepted is back up to the higher growth rates. And you'll see that come through over the next few months because of the lag time in the process.

[Operator Instructions] We will take our next questions from our participant, Mr. Nick Dempsey from Barclays.

I've got 3 questions. So the first one, when you're negotiating subscription renewals, I understand that you won't be putting through an inflationary price increase. But when you're making your case for how much extra value you've delivered and you hope to be paid for that, doesn't it help in your negotiations that the other cost lines of your customers are all going up 5%, 6%, 8%, 13%, and therefore, it's not shocking that they would pay you 5% more or 6% more than last year? So even though you don't obviously put through inflation price increases, are you still being helped by an inflationary environment? And could that change? Second question. When you say on Legal, the renewal rates are strong and the positive momentum in new sales is continuing, given that about 80% of revenues are subscription, is there any reason why you would not again achieve the 5% organic revenue growth in Legal in '23 that you saw in '22? And the third question, now that the Exhibitions division is heading back towards the numbers that you achieved before the pandemic, does it make sense to look to sell this division at some point? Clearly, it was a source of volatility in the last few years that it would have been nice to avoid and the scale of the division is pretty small in the group.

Well, let me cover each one of those in order here. If you looked at -- first question was around subscription renewals and the relative perception of those in an inflationary environment. We think of what we sell to our customers as something that is of increasing value to them over time, both because we have broader data sets or the broader content sets, we have increasing and sophisticated analytics and higher-value decision tools, and therefore, we sell on their value and their perceived value. And I agree with you to some extent that when other things in the world get more expensive, the perception of value might -- that we -- of what we are selling would be enhanced, and therefore, our customers should want more of them, should use them more and, therefore, continue to support our revenue growth. So even though there's not a direct calculation there, it's a part of our approach of selling value. And when the relative value increases, we should at least do as well as we did before, if not slightly better. On Legal, you said -- yes, if you asked us, is it going to be similar? Yes. Renewals and new sales are continuing to do well. Momentum is strong. It remains strong. There's no reason to believe that based on what we've seen that the trends are heading down. However, we still have about 10% of that division that is print. That is a little bit lumpy. So you don't know exactly what's going to happen in any 1 6- or 12-month period in the short term, but we do know which direction it's going over the medium to long term, and that's an improving long-term growth trajectory. On Exhibitions, in the near term here, as you might understand, and as I mentioned earlier, we remain 100% focused on the growth opportunity from the new reopening and the introduction of these new data-driven digital tools we're using. Over time though, the key issue is what kind of value uplift we will be able to drive for our customers and for the business as a whole, therefore, through the wider deployment of these higher value-add analytics and decision tools. But given that we're still in the reopening stage here where many exhibitions are happening for the first or second time since COVID, and we're in the early stages of this roll up, it's much too early for us to estimate or even try to form an opinion of what kind of value that will create at this point in time. So that's where we're going to leave it for now.

We will take our next question from Sami Kassab from BNB Paribas.

I have my 3 questions as well. The first one is on STM and Legal. They have accelerated, but have you reached a plateau? Or would you expect over time that growth rate can accelerate further in Legal, in particular, and in STM, as we recently heard from Thomson Reuters who suggested further growth acceleration? Secondly, there has been quite a lot of talk on ChatGPT and other text-generative AI. What impact do you see this development having on the group and especially on the Legal division? And lastly, how much of Reed Exhibitions revenues are now derived from digital tools?

Yes. I will cover all of those in order, too. In the different divisions, Legal and STM, as you might have heard from the 2 seminars we've had on those individual divisions in the last year or so, both of those division heads have articulated the clear objectives for that growth objective for them, which is to continue on this improving growth trajectory and because this is driven by the business mix shift towards higher-growth analytics and decision tools and, of course, in both of those divisions also supported by the gradual reduction in the print drag on the growth rate. Their objective is to continue down this path. But of course, as we've heard, the subscription percent in each one of those is 3/4 of the division is multiyear subscriptions, which means that they're working on improving the long-term growth rate, but it's going to have to be 1 percentage point at a time, and it will be, in the short term, influenced by possible volatility on the lumpy print revenues in any 1 year, even though that effect would also reduce this over time. ChatGPT. I mean RELX is a big user of AI technology, and it has been, as you know, for many years. Generative AI or the technologies behind ChatGPT, that's the next step on this journey. And it's steps like this that actually have enabled us to grow and develop in the way that we have developed as a company. I mean as a matter of fact, we consider our ability to identify and leverage new tools like this, a competitive advantage of ours. We proactively seek them out. We work with them often in partnerships, and where we see opportunities to create products, we do that to improve our customer outcomes, and sometimes we look for opportunities instead to leverage the technologies to improve our own internal processes and efficiencies. I mean this has been our approach for many years. It will continue to be for many years to come. ChatGPT or perhaps more importantly for us, the GPT underlying large language model structure that's behind it, that's an important step, but it's only one step of many. There will be many more to come, and we're very excited about it. We have already worked with the underlying GPT technology for a while. We'll continue to do that with the next generation. I think it's going to be a big opportunity for us to continue to incorporate it, both in the way we serve our customers and interact with them but perhaps, most importantly, in the way we actually operate and run the company in our internal professionals and their processes. Let me just make sure, the last question you asked was?

I'd like to take it. Your digital revenue in Exhibitions. If you look in, Sami, in the disclosures, you'll see that where we actually charge separately for the digital service, that's the revenue -- it's about 7% of the division but actually was -- and that's growing strongly. But what's more important actually is how you use these digital tools to enhance the experience of both the exhibitor and the attendee at the event. So ultimately, it comes through in the face-to-face revenue and what you're charging exhibitors and indeed attendees in some cases to be at the event because they can get more value out of it because of these digital tools.

We will take our next question from Lisa Yang from Goldman Sachs.

I have a few questions as well, please. Firstly, on Risk. Obviously, we saw a nice acceleration in the line growth to 8%. Do you think that sort of 8% is sort of reasonable for 2023? And I think that sounds consistent with your comment as well about growth remaining in line with historical trends. And could you maybe elaborate a bit more on the drivers of the growth there? Do you continue to see insurance accelerating for 2023 or maintaining the good run rate of H2 2022? Are you seeing any slowdown yet, especially the transactional component within Business Services? And what are the trends you're seeing as well in the reference business in product identity? That would be really helpful. Second question is on Exhibitions. Could you please tell us where you ended at the end of 2022 in terms of like-for-like revenue for your shows versus 2019? And what are your expectations for 2023, especially if you're expecting margin to go back to close to that 26% level? And can you also maybe comment on what you're expecting as well in terms of contribution of price increases and how much contribution you're expecting from your China JV? I know it's mainly an impact on your EBIT but used to be quite meaningful. And so I'm just wondering like what are you assuming in terms of getting to that sort of close to 26% level. And on Exhibitions as well, are you planning -- given that this business seems to be doing much better now, are you expecting to roll any new shows? That the second question. And the last one is if you can give us an update in terms of what you're expecting on tax. I think 2022 tax rate ended a little bit lower than we expected. So what should we expect for 2023 and on interest costs as well? Okay.

Okay. I will cover the first one. And then I'll hand the rest over to Nick to cover those. So if I understand you correctly, you're talking about the growth rate of Risk, the current run rate and the near-term outlook for it. As you've heard, our long-term view on Risk is that the opportunity set in this segment is such that our objective there is to continue to grow in this range for many years to come. And the range we've been in the last few years, of course, fluctuated a little bit, sometimes up a point, sometimes down depending on some of the transactional revenue streams during that year. And while we can see what's going on now and what has happened recently, it's always very hard for us at this time of the year to try to predict exactly how those revenues -- transactional revenues will behave in especially in the second half of the year because it's so many months out. But I can tell you what you would expect in this kind of economic environment, which is that some streams would possibly slow down their growth rate a little bit. I mean, at this moment, as you might guess, over the last few months, at the end of last year and currently, we've seen some pockets in our Business Services side of Risk where the growth rate has slowed a bit relating to personal financial transactions and others, right? On the other hand, we have seen a pickup in growth rate in several other segments, including some financial compliance and, most importantly, in the Insurance segment where both insurance shopping and switching has picked up, which it typically does when the economic environment slows down a little bit the way it has. So we're seeing the kinds of patterns that we have historically. And at the moment, in the last few months and currently, the slight slowdown in some subsegment is offset by the slight pickup in the other segments. And if anything, you net it up, the slight positive segments are probably marginally outweighing the former negative outlook, and they are the negative transaction on the growth rate. But it's very hard to say, of course, where exactly that will be later in the year. But again, I think you have to look at this division as being in a range of growth over a long period to come. And there will always be a little uncertainty about what the growth rate will look like 6 to 12 months out. Now I'm going to hand that over to Nick to cover the others.

So Exhibitions, you asked about the like-for-like. Obviously, that improved as we went through '22. In the second half, we rounded about 90% for those shows that had a comparable event prior to COVID. Looking to '23, I think we'll have to see how that evolves. We'll have some events that are still coming back for the first time, China cycling events that are happening for the first time since COVID. So we'll see. You asked about China joint venture profit. Yes, that was not as strong because of the difficulty operating in China. That did have some impact on the margins. And although the revenue line was strong, I think, relative to the expectations, the lack of JV profit held back the bottom line a bit. You asked about launches, and we have it. Yes, we are launching again. We have about 15 launches planned for '23, not quite as many as we had historically. But that number is coming up. And your other question is on interest and tax, the tax rate. The 21.3% we had in the full year '22 is a normal sort of rate within that 21%, 22% range. The U.K. corporation tax rate, of course, is -- they've announced is going up in April, although that's changed a few times and been unannounced and then reannounced. But if that goes ahead, that would add a bit to the tax rate. So over time then, you'd expect it to settle in the sort of 22% to 23% range, and most of that step-up would occur in this year. And you asked about interest cost, as I said in the presentation, interest cost in '20 -- average cost of gross debt in 2022 was about 3%. It's currently about 4%. And based on forward curves, it would change much from that, although we'll see what happens to interest rates. But that's a good starting point for your charging what interest is going to be this year.

We will take our next question from Thomas Singlehurst from Citi.

Yes. I was going to joke that it's Harvey from Allen & Overy, but no, it's definitely Tom from Citi. The question -- first one, I'm going to come back to the generative AI. I mean you -- I think you answered it on the Legal side. And I see the point around embedding those kind of tools in your workflow solutions. I'm interested on the STM side. There's been some discussion around whether it's going to set things like the sort of process of preprints back because they'd just be more -- the signal-to-noise ratio will go down. Can you just talk about how it might impact sort of behavior and sort of fraud levels within STM and whether that has any implications to your business? That was the first question. Secondly, on Exhibitions, the question was -- I suppose, very simply, what proportion of your sort of shows are running in the right time slot in 2023 or anticipated to run in the right time slot in 2023? And on the back of that, what's the right level of recovery versus 2019, adjusted for which shows are taking place at the right time? And then finally, in terms of M&A, obviously, ongoing spend on acquisitions, can you just talk about what we're most likely to see spend in terms of operating divisions?

Okay. I'll cover the first question. Then I'll hand over the rest to Nick here to cover. On -- again, back on generative AI and GPT-based tools at this point. Again, we believe this is one significant development, but it's one of many. It's one step but long journey. And yes, it will over time -- our tools like this over time will influence, I think, many of the things we do, not just in the Legal division but also in the other divisions, including in STM. And of course, we have had our people look inside this for quite a while. We've looked at the tools behind this, the large language models and experimented with them. And we also looked at how individual users can use this, in particular, as you said, authors and submissions in the scientific world. And we have developed and put in place a policy with authors and editors to clarify how tools like the ChatGPT can be used, how it can be used as a tool to enhance articles but also transparently stating how it's been used, how we disclose, how it's being disclosed and used is becoming standardized within the industry. And the way I see it is this is going to continue to evolve. Whether then that specifically means that certain types of tools, like you said, preprints and others might have -- be seen to have a different value if they haven't been peer-reviewed, if they haven't been rigorously edited and checked for different tools and methodologies. I think that remains to be seen. I still believe, again, that the value and importance of trusted contents and brands in this kind of environment should not go down. That's probably my conclusion on that. But it's going to continue to evolve. We're already in the process of testing and experimenting with the technology for our internal processes for our own processes, our own word processing as well as our own technology tools for our own employees to see if there are ways that we can enhance it but without using it as a product itself.

So Tom, your question on the Exhibitions schedule for '23. Outside of China, almost all the Exhibitions are scheduled to run in their normal slots, but we'll see whether that's possible, and we've become very good at being flexible and adapting if we need to. Your questions on M&A and which business areas would it -- would that fall into. I mean the first thing to say is all our businesses are focused primarily on organic development, of course. We will use acquisitions and make acquisitions where we see ways of enhancing and accelerating the organic development. If you look back over the last few years, the Risk division has had more of the acquisition capital, but that's a product of opportunity and the dynamics of that particular segment. We're certainly willing and actively always looking in all 4 business areas.

We will take our next question from Matthew Walker from Credit Suisse.

Yes, it's Matthew Walker from Credit Suisse. I also had a question on GPT, which is you mentioned how it can be used in a defensive mode to enhance your products for customers and also to benefit your staff internally to sort of save time, et cetera. What do you see from the possibility of it being used offensively against you from start-ups and -- or maybe even larger companies? You've got like a lot of deep data in all the different divisions. To what extent can GPT pull out that data with or without your consent? And how easy would it be for a rival company to build some effective products based on that technology and start charging for them? So if you could just give us a bit of color on how that technology might or might not be able to be used against you? The second thing is, could you give a bit more color? You answered a little bit, but I just wanted a bit more color on Risk transaction outlook for this year. I mean it's obvious that reinsurance is recovering. Can you give us some products or a feel for the different types of products? You mentioned personal finance, but could you mention some different products which might be experiencing a slowdown in the other side, the noninsurance side, of transactions and give us a sense of where things may or may not be vulnerable and what current growth rates are like? And then finally, on Exhibitions. Could you tell us what your rebookings rate was both the first half and second half?

Back to GPT. I mean maybe I was not clear enough here. We see the GPT fundamentally as an opportunity to continue to enhance things that this is an underlying -- the underlying technology, the large language model and the generative AI behind it. That's something that we see as one step in technology development, something we've been on for a very, very long time. I mean some of you may recall, we've talked about AI and machine learning in some of our seminars many years ago and how we include this. We believe, as I said, that our ability to identify and leverage those ahead of others is a competitive advantage. And I believe that this is not a defensive tool for us. This is the main driver. Using technologies like this has been the main driver of the improvement in our growth rate and the increasing value-add in our analytics and our decision tools. And I do not believe that this step is an exception to that or the future step should be an exception. We seek these partners out. We see the individual developers out. There were smaller companies you talk to, even the ones that come from big companies. We often look to develop partnerships with them and do licenses and collaborations early here, and we've been on this for quite a while, and we've been experimenting with building things for quite a while. So we believe that this is a tool that we're particularly well positioned to leverage in a positive, proactive way. When you ask, what can other people do, there will always be technologies that are useful. And if they're useful to us, they will be useful to others. But as we've said many times before, the value that we bring in our…

So your question on rebooking rates. Yes, they improved as we went through '22. You can see that in the revenue numbers and those like-for-like comparisons I was talking about and how this first half was like 75%, second half 90%. So -- but you see that that's where the rebooking is coming through.

We will take our next question from Konrad Zomer from ABN AMRO.

Konrad Zomer, ABN AMRO. Just one question on Exhibitions. When you mentioned that the margins will return to prepandemic levels, which was about 26% from 17% last year, how much of the GBP 100 million of cost savings you put through in 2020 do you think is going to be permanent, so to speak? And how much of that will move back up now that revenues have started to move back up?

I'll let Nick cover this here.

Yes. The -- as you say, we've fundamentally improved the cost structure, the portfolio changes we made, and we permanently discontinued a number of shows and representing about 10% of revenue. So there's clearly were -- the weaker events of that also helps structurally with the margin. Yes, clearly, the cost base of the business evolves, particularly as you come back with the events. But essentially, the structure is -- the structural changes are permanent.

But that would imply that GBP 100 million already reflects about a 10 percentage points on your margin. So then it wouldn't be a very ambitious statement to suggest that margins will return to prepandemic levels. I mean it suggests that they will exceed prepandemic levels relative to...

No, you have to -- but -- yes, obviously, the scale of the business is different if we've taken off 10% of the revenue off the top. So you have to get that into account, okay?

Okay. Well, I think that looks like -- that's the last question. So then I'd like to -- or is there another question on the line?

There are no further questions. At this time, I'd like to turn the conference back to Erik for any additional remarks. Please go ahead.

Okay. Well, just -- I just want to say thank you all for joining us on our call today. I look forward to talking to you again soon.

Ladies and gentlemen, this concludes today's call. Thank you for your participation. You may now disconnect.